| Stephen Roth Klapper, MD FACS | |
|
11900 N Pennsylvania St, Suite 104, Carmel, IN 46032-4693 | |
| (317) 818-1000 | |
| (317) 818-1001 |
| Full Name | Stephen Roth Klapper |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 32 Years |
| Location | 11900 N Pennsylvania St, Carmel, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316910607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 01048211A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Eskenazi Health | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stephen R Klapper Md Llc | 8123168366 | 2 |
| University Family Physicians, Inc. | 7911992797 | 424 |
News Archive
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be independent risk factors for retinopathy in people using hydroxychloroquine, an antimalarial drug commonly used to treat lupus, rheumatoid arthritis and other diseases.
Named for Friedrich Best, who characterized the disease in 1905, Best disease, also known as vitelliform macular dystrophy, affects children and young adults and can cause severe declines in central vision as patients age.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that it has submitted a Clinical Trial Authorization application to the Medicines and Healthcare products Regulatory Agency to initiate a Phase 1/2 study of ALN-AAT02, an investigational RNAi therapeutic targeting alpha-1 antitrypsin for the treatment of AAT deficiency-associated liver disease.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
› Verified 8 days ago
| Entity Name | University Family Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043275787 PECOS PAC ID: 7911992797 Enrollment ID: O20040420000393 |
News Archive
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be independent risk factors for retinopathy in people using hydroxychloroquine, an antimalarial drug commonly used to treat lupus, rheumatoid arthritis and other diseases.
Named for Friedrich Best, who characterized the disease in 1905, Best disease, also known as vitelliform macular dystrophy, affects children and young adults and can cause severe declines in central vision as patients age.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that it has submitted a Clinical Trial Authorization application to the Medicines and Healthcare products Regulatory Agency to initiate a Phase 1/2 study of ALN-AAT02, an investigational RNAi therapeutic targeting alpha-1 antitrypsin for the treatment of AAT deficiency-associated liver disease.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
› Verified 8 days ago
| Entity Name | Stephen R Klapper Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609104082 PECOS PAC ID: 8123168366 Enrollment ID: O20091218000080 |
News Archive
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be independent risk factors for retinopathy in people using hydroxychloroquine, an antimalarial drug commonly used to treat lupus, rheumatoid arthritis and other diseases.
Named for Friedrich Best, who characterized the disease in 1905, Best disease, also known as vitelliform macular dystrophy, affects children and young adults and can cause severe declines in central vision as patients age.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that it has submitted a Clinical Trial Authorization application to the Medicines and Healthcare products Regulatory Agency to initiate a Phase 1/2 study of ALN-AAT02, an investigational RNAi therapeutic targeting alpha-1 antitrypsin for the treatment of AAT deficiency-associated liver disease.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Roth Klapper, MD FACS 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Stephen Roth Klapper, MD FACS 11900 N Pennsylvania St, Suite 104, Carmel, IN 46032-4693 Ph: (317) 818-1000 |
News Archive
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be independent risk factors for retinopathy in people using hydroxychloroquine, an antimalarial drug commonly used to treat lupus, rheumatoid arthritis and other diseases.
Named for Friedrich Best, who characterized the disease in 1905, Best disease, also known as vitelliform macular dystrophy, affects children and young adults and can cause severe declines in central vision as patients age.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that it has submitted a Clinical Trial Authorization application to the Medicines and Healthcare products Regulatory Agency to initiate a Phase 1/2 study of ALN-AAT02, an investigational RNAi therapeutic targeting alpha-1 antitrypsin for the treatment of AAT deficiency-associated liver disease.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
› Verified 8 days ago
Dr. Kevin Enpei Lai, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St Ste 1000, Carmel, IN 46290 Phone: 317-805-2240 | |
John H Abrams, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11455 N Meridian St, Suite 100, Carmel, IN 46032 Phone: 317-846-4223 Fax: 317-846-6063 | |
Derek T Sprunger, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 201 Pennsylvania Pkwy Ste 100, Carmel, IN 46280 Phone: 317-817-1333 | |
Dr. Jerry Richard Myers, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 13405 Cherry Tree Rd, Carmel, IN 46033 Phone: 317-844-1436 | |
Dr. Mark Matson Kaehr, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10585 N Meridian St Ste 100, Carmel, IN 46290 Phone: 317-571-1501 Fax: 317-571-4806 | |
Dr. Jennifer Marie Nottage, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St, Carmel, IN 46290 Phone: 317-817-1765 |